Sell Dell!: Against...
Financial: Financial Services
Mesabi Trust (MSB: NYSE)
$24.73 0.12 | 0.49%
05/24/12 - 04:09 PM ET
153.96K / 138.30K
Vol / Avg. Vol:24.85 / 24.61
Open / Prev. Close:24.33 - 24.99
Today's Range:18.85 - 34.97
52 Wk Range:-3.39%
Performance YTD:TheStreet Rating:
Portfolios with MSB
- Portfolio NameUser Type
- ContributorTop-Yielding Financial Serv...
- UserUSB
- UserMyStock
- UserDragon-King and Naked-Swan ...
- UserPeter's Portfolio
- UserTNSTKS
- Contributor10 Small-Cap Stocks That Tr...
- Contributor10 Dividend Stocks With Up ...
- UserCoreFolio
- Contributor34 Dividend Stocks Increasi...
Latest MSB Headlines from TheStreet
- Mesabi Stock To Go Ex-dividend Tomorrow (MSB) 04.25.12 | 09:04 am
- 3 Ex-Dividend Stocks With Buy Ratings 01.25.12 | 10:01 am
- Mesabi Stock To Go Ex-dividend Tomorrow (MSB) 01.25.12 | 10:01 am
- Mesabi Stock To Go Ex-dividend Tomorrow (MSB) 10.25.11 | 09:10 am
- Mesabi Trust (MSB): Today's Featured Financial Services Winner 10.17.11 | 05:10 pm
- 7 Stocks Rising on Unusual Volume 10.17.11 | 02:10 pm
- Mesabi Stock To Go Ex-dividend Tomorrow (MSB) 07.26.11 | 10:07 am
- Mesabi Stock To Go Ex-dividend Tomorrow (MSB) 04.26.11 | 09:04 am
- 10 Small-Cap Stocks That Tripled in 2010 12.15.10 | 06:12 am
- 34 Dividend Stocks Increasing Payouts 10.22.10 | 03:10 pm
Press Releases for MSB
- Intervertebral Disc Repair Phase 2 Trial Update - PR Newswire 04.17.12 | 06:04 am
- Mesabi Trust Declares Distribution - Business Wire 04.13.12 | 05:04 pm
- Mesabi Trust Declares Distribution - Business Wire 01.13.12 | 05:01 pm
- Positive Results From Phase 2 Trial Of Mesoblast's Adult Stem Cell Therapy Presented At The American Heart Association Annual Meeting - PR Newswire 11.14.11 | 04:11 pm
- Mesoblast Cleared To Begin First Phase 2 Clinical Trial For Eye Diseases - PR Newswire 10.24.11 | 03:10 am
- Mesabi Trust Declares Distribution - Business Wire 10.14.11 | 05:10 pm
- Mesoblast Receives Clearance To Begin First European Trial Of Allogeneic Or 'Off-The-Shelf' Stem Cell Treatment For Heart Attacks - PR Newswire 09.05.11 | 06:09 am
- First Minimally-Invasive Procedure Performed In Mesoblast's Phase 2 Stem Cell Trial For Lumbar Disc Repair - PR Newswire 08.22.11 | 07:08 am
- Mesabi Trust Declares Distribution - Business Wire 07.15.11 | 05:07 pm
- Mesoblast Receives FDA Clearance For Phase 3 Bone Marrow Transplant Trial - PR Newswire 07.07.11 | 06:07 am
Partner Headlines for MSB
- 5 High-Yield Financial Dividend Stocks With Strong Earnings, Manageable Debt Ratios - Seeking Alpha 05.06.12 | 09:05 am
- 8 Names Yielding Over 9%: A Look At Their Hedging Costs - Seeking Alpha 01.01.12 | 08:01 am
- China Collapse Means Iron Ore Collapse - Seeking Alpha 05.04.11 | 09:05 am
- Company News for April 14, 2011 - Corporate Summary - Zacks 04.14.11 | 10:04 am
- Why True Diversification Is Important - Seeking Alpha 02.13.11 | 06:02 am
- Northshore Mining's January Shipping and Its Implications for Mesabi Trust's Q1 Distribution - Seeking Alpha 01.24.11 | 06:01 am
- Mesabi Trust Not Aware of Developments Explaining Market Activity - Benzinga 12.16.10 | 01:12 pm
- 19 Dividend Stocks Heating Up Their Yields - Seeking Alpha 10.22.10 | 06:10 am
- Big Commodity Dividend Plays - Seeking Alpha 07.26.10 | 08:07 am
- Mesabi Trust Is Picking Up the Pace - Seeking Alpha 07.26.10 | 07:07 am
